Mirum Pharmaceuticals Inc Corporate Analyst Meeting Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Mirum Pharmaceuticals Inaugural IR Day Virtual Program. (Operator Instructions) As a reminder, today's program may be recorded. And now I'd like to introduce your host for today's program, Ian Clements, Chief Financial Officer. Please go ahead, sir.
Thanks very much, indeed, and good morning, everybody. Welcome to Mirum's Inaugural Investor Relations Day. For those of you who don't know me, I'm Ian Clements, CFO at Mirum. I'm super excited to be here today and glad that you could all join us to be part of what I believe promises to be a great event.
Before starting, I would like to remind everybody that we will be making forward-looking statements today. So investors should read the risk factors set forth in Mirum's Form 10-K for the year ended December 31, 2019, and any subsequent reports filed with the Securities and Exchange Commission. So I do encourage you to visit the SEC website to see our latest filings.
Before turning
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |